Grand Haven’s UV Angel is ramping up the manufacturing of technology that neutralizes airborne pathogens and could help eliminate the COVID-19 virus in particles.
The company is working with Corning Inc. in New York to scale the supply for its UV Angel Clean Air, which was initially designed to address health care associated infections by neutralizing airborne viruses, bacteria, and fungi in medical, dental, and other clinical environments.
The COVID-19 pandemic has accelerated deployment to include retail spaces, restaurants, commercial real estate, schools, hotels, and other industries.
“We believe our patented ultraviolet (UV-C) light air treatment technology is a game-changer in the fight against infectious diseases,” says Tom Byrne, CEO of UV Angel. “Our design and engineering expertise together with Corning’s manufacturing capabilities enables UV Angel to rapidly produce clean air products to meet the fast-growing market demand.”
UV Angel Clean Air combines standard in-ceiling lighting with a UV-C light air treatment center. Air is pulled into the sealed high-intensity UV-C chamber, which neutralizes and eliminates up to 99.99 percent of pathogens. The treated air is then returned to the room.
“Corning has long provided products to create safer and more resilient communities,” says Martin J. Curran, executive vice president and innovation officer for Corning. “We manufacture products that reduce mobile emissions, products that enable antimicrobial coatings and surfaces, and products that remove small particulates from indoor and outdoor environments. We are pleased to support UV Angel to scale a technology that could help in the world’s fight against this pandemic.”
UV Angel products come with a data platform that provides users the ability to track key performance indicators and access treatment data.